Cristina
Legido-Quigley
CLQ LAB
Neuro & Metabolic Clinical Research
RESEARCH
Dr Legido-Quigley's Lab works in PanMolecular Precison Medicine, using molecules that are new and achieve personalised treatments. Her work focuses in neuro and metabolic diseases and particulalrly in disease that affects the brain and the liver, like Alzheimer's Disease and Diabetes.
The lab's science is at the interface between chemistry and medicine and her lab houses biotechnology and data science to allow the detection of thousands of small molecules / lipids.
These molecules are measured with mass spectrometry instruments and then, data analytics, including machine learning, is performed to both discover biology and predict health & disease outcomes. In order to translate results into the clinic we also work with clinical trials and evidence portfolios.
CLICK the illustrations below to read about our work highlighted in the press
CLICK
TO ACCESS
PUBLICATIONS
Lipids are depleted in Alcoholic related Liver Disease. (2023)
CLQ was awarded 4.940.250 DKK by The Lundbeck Foundation to investigate lipids and Alzheimer’s & Diabetes (2021-2025)
Lipidomics of human tissue reveals diversity between body areas. (2020)
Higher brain glucose may mean more severe Alzheimer's. (2017)
DONORS & SPONSORS
We are very grateful for the samples that volunteers and donors give us and make our research possible.
As well, we thank all our collaborators and the funding bodies and sponsors that fund our research.
CURRENT FUNDERS:
.
PREVIOUS FUNDERS OVER THE YEARS:
.
